Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study (Q36768921)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 December 2012
edit
Language Label Description Also known as
English
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
scientific article published on 21 December 2012

    Statements

    Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study (English)
    John Farley
    William E Brady
    Vinod Vathipadiekal
    Heather A Lankes
    Robert Coleman
    Mark A Morgan
    Robert Mannel
    S Diane Yamada
    David Mutch
    William H Rodgers
    Michael Birrer
    21 December 2012
    134-140

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit